Dr. Stephen Henry Schultz, MD

Dr. Schultz practices at New Hanover Regional Medical Center Rehabilitation - Unit in Wilmington, North Carolina.

Dr. Schultz's NPI, 1962418475, was assigned on August 1, 2006. Dr. Schultz holds New York license 193893.

Dr. Schultz's primary practice is New Hanover Regional Medical Center Rehabilitation - Unit, at 2131 South 17th Street, Wilmington, NC 28402 in New Hanover County. The practice phone is (910) 667-5619.

Dr. Schultz's primary practice is New Hanover Regional Medical Center Rehabilitation - Unit in Wilmington, North Carolina. Dr. Schultz is also affiliated with Novant Health New Hanover Regional Medical Center. The medical group on file is Novant Health Heart & Vascular Institute, Wilmington Main. Dmand AI also links Dr. Schultz to 2 more hospitals, 4 group practices and clinics, 3 medical groups, 1 behavioral health center and 1 breast imaging center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schultz practices, 10 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Schultz's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Schultz is licensed in New York.

CMS data shows 59 Medicare services from Dr. Schultz across 2 procedure codes in 2024, all of them office visits, for 61 Medicare patients. Medicare paid $3,441 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 61 Medicare patients who saw Dr. Schultz in 2024. The largest group is 75 to 84, with 24 patients. 69% of them have high blood pressure, and 66% have high cholesterol. 46% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schultz's median patient age at 65, with 50% women.

In 2024, Dr. Schultz wrote 1,427 Medicare Part D claims for 251 patients. 91% of them were for generic drugs. CMS names the drug for 853 of them, across 34 drugs with 11 or more claims each, at $26,115 in total drug cost. In 2023, CMS named 1,378 claims across 54 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Schultz for performance year 2024, reported through an alternative payment model (APM). Dr. Schultz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Schultz in 2015. The most frequent topics are Checklist, Internship and Residency and Patient Care Team. Dr. Schultz has published most often in Fam Med. Dr. Schultz's most frequent co-authors are Douglas Michael Carney, MD, Mathew J. Devine, DO and Stephen J. Lurie, MD.

CMS Open Payments shows 6 general payments to Dr. Schultz from 4 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 100% of the total. Butterfly Network, Inc. paid the most, $68.